Salute e Benessere

Huawei's new Health Lab in Finland is Advancing Global Efforts in Health &…

Advancing the Global Field of Sports Science and Health Research Advancing the Global Field of Sports Science and Health Research Acknowledging the growing need in the health and fitness market, Huawei has pledged to deepen its research in health monitoring algorithms through its wearable technologies. This led to the establishment of three HUAWEI Health Labs across the globe since 2016:Xi'anand Songshan Lakes inChina, and now one inHelsinkiofFinland. HUAWEI Health Lab in...
PR Newswire
30/10/2023

Auto Injectors Market size worth $245.14 Billion, Globally, by 2030 at 23.2%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=27669 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=27669 Browse in-depth TOCon" Auto Injectors Market " 202 - Pages 126 – Table 37 – Figures Revolutionizing Healthcare: Auto Injectors Market Pave the Way for Hassle-Free Drug Delivery Auto Injectors, the groundbreaking medical devices designed to overcome needle-based drug administration...
PR Newswire
30/10/2023

Enteral Feeding Formulas Market to Reach $12.7 Billion, by 2032 at 7.4% CAGR…

Request Sample of the Report on Enteral Feeding Formulas Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/11789 Request Sample of the Report on Enteral Feeding Formulas Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/11789 Enteral feeding formulas, often referred to as enteral nutrition or tube feeding formulas, are specialized liquid or semi-liquid nutritional products intended for direct administration into the gastrointestinal...
PR Newswire
30/10/2023

Gene Therapy Market Worth $23.9 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857962 Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857962 Browse in-depth TOC on "Gene Therapy Market" 349 - Tables 48 - Figures 288 - Pages Gene Therapy Market Scope: Gene augmentation subsegment accounted is the fastest-growing of the gene therapy market by type Among the type subsegments, the market is segmented...
PR Newswire
30/10/2023

MapLight Therapeutics Closes $225 Million Series C Funding Round to Advance…

"MapLight has built a diverse pipeline of innovative neuroscience therapeutics targeting a spectrum of Central Nervous System (CNS) disorders where the challenges faced by patients and families are significant and the unmet need is high. This financing will fuel the important clinical development necessary to bring these innovative therapies to patients," said Christopher Kroeger, M.D., MBA, Chief Executive Officer, and Founder. "The enthusiasm and continued support of our…
PR Newswire
30/10/2023

Trading by management and close relations of management

Please read the full announcement in PDF Attachment 2023_59_Trading_by_management
Nasdaq GlobeNewswire
30/10/2023

Olight 2023 Breast Cancer Charity Campaign: Illuminating Hope with Breast Cancer…

A notable addition this year was an offline setting in the USA: Olight established an Awareness Booth in Frisco, Dallas, in partnership with NBCF. This booth provided breast cancer information and fostered community participation against the disease. Olight also gifted volunteers and patients with special flashlights, pink pouches, etc. on site. Additionally, 300 patients will receive Olight flashlights and other gifts in HOPE Kits. A notable addition this year was an offline setting in the...
PR Newswire
30/10/2023

Can Diabetes, Weight-Loss Drugs Get Even Better

Click here to view the custom infographic of the Lexaria Bioscience Corp. editorial. Click here to view the custom infographic of the Lexaria Bioscience Corp.editorial. Diabetes and Obesity Rates Soaring According to the U.S. Centers for Disease Control and Prevention, 37.3 million Americans have diabetes, while another 95 million adults, one in three, have prediabetes, of which 80% are unaware of having it. Globally, the World Health Organization estimates 422 million people had...
PR Newswire
30/10/2023

MAR Weekly Repport_VIRBAC SA_23 to 27 October 2023

Statement of transactions in own shares from 2023-10-23 to 2023-10-27BNP PARIBAS Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares...
Nasdaq GlobeNewswire
30/10/2023

NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for…

The NCCN Foundation® provides funding for the NCCN Guidelines for Patients. All guides are available free-of-charge at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App. The NCCN Foundation® provides funding for the NCCN Guidelines for Patients. All guides are available free-of-charge atNCCN.org/patientguidelinesor via the NCCN Patient Guides for CancerApp. "People with cancer should be able to live the best life possible. That means not just treating...
PR Newswire
30/10/2023

Evoke Announces Appointment of Group President Cris Morton

"I am thrilled to have Cris join the leadership team at Evoke," said Reid Connolly, CEO & Founder of Evoke. "Cris's experience, his leadership style, his passion for creative problem solving, and his commitment to keeping our clients and what's important to them at the center of everything we do made Cris the ideal leader for where the business is today and where we are going." "I am thrilled to have Cris join the leadership team at Evoke," saidReid Connolly…
PR Newswire
30/10/2023

New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug…

"We have long suspected that SGLT-2 inhibitor use is associated with extremely low GlycoMark results, even lower than typically seen for patients with persistent hyperglycemia," said Sam Fereidouni, MD, MHSA, Medical Director at Aveon Health, and lead investigator on the study. We hypothesized that extremely low GlycoMark results were not an indicator of very poor glycemic control but were rather indicating compliance with the medication as prescribed and achieving the desired effect…
PR Newswire
30/10/2023

Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce…

"For over 40 years there have been a multitude of failed attempts to create a herpes vaccine using recombinant protein subunit-based vaccines. The data shows this approach will not work for HSV," said Agustin Fernandez III, CEO and Founder at RVx. "We are confident a live attenuated vaccine is the only way to combat and prevent herpetic disease. We are excited that the top vaccine experts in China share our vision. It is an honor to tackle this mission with our partners at…
PR Newswire
30/10/2023

King Faisal Specialist Hospital and Research Centre Announces Rapid Whole Genome…

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month...
Nasdaq GlobeNewswire
30/10/2023

Aquinnah Pharmaceuticals Advances Oral Small Molecule Program Targeting…

Administration of the compound once daily in preclinical models was sufficient to achieve a strong reduction of abnormal tau protein, which is the key protein contributing to loss of memory and cognition in Alzheimer's disease. Because Aquinnah's compound acts through a unique approach, this new compound also has the potential to be used in combination with anti-amyloid drugs, recently approved by the FDA. If successful in clinical trials, Aquinnah's treatment could benefit patients suffering…
PR Newswire
30/10/2023

Impedance-Based TEER Measurement System Market to Reach US$135.4 Million by…

The global impedance-based TEER measurement system market value is expected to increase from US$ 73.93 million in 2023 to US$ 135.40 million by 2033. Over the forecast period, impedance-based TEER measurement system demand is set to rise at a CAGR of 6.2%. The global impedance-based TEER measurement system market value is expected to increase from US$ 73.93 million in 2023 to US$135.40 millionby 2033. Over the forecast period, impedance-based TEER measurement system demand is set to...
PR Newswire
30/10/2023

AliveDx receives three IVDR CE marks for its Multiplexed Autoimmune Diagnostics…

- The MosaiQ AiPlex CTD microarray immunoassay designed as an aid in diagnosis of Connective Tissue Diseases - The MosaiQ AiPlex CTD microarray immunoassay designed as an aid in diagnosis of Connective Tissue Diseases - The multiconstituent MosaiQ AiPlex CTD Quality Controls EYSINS,Switzerland,Oct. 30, 2023/PRNewswire/ -- AliveDx is proud to announce it has received three CE Marks for: Its MosaiQ Centromere Protein B (CENP-B) microarray, its MosaiQ AiPlex CTD (Connective Tissue...
PR Newswire
30/10/2023

KFSH&RC's Capacity Command Center is a Pioneering Model for Achieving Maximum…

Bed waiting time reduced from 32 hours to 6 hours Since its launch in September 2021, the Center has executed over 170,000 intervention procedures, significantly reducing bed waiting times from 32 hours to 6 hours. The emergency department has also seen a 14% reduction in waiting times. Furthermore, waiting times in the pharmacy and laboratory have improved, with over 90% of beneficiaries receiving services in less than 15 minutes.Since its establishment, the Center has become the primary...
Nasdaq GlobeNewswire
30/10/2023

Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 |…

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1907 Download PDF Brochure:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1907 The accessibility and affordability of non-steroidal anti-inflammatory drugs (NSAIDs) make them popular for the management of pain and inflammation. Due to the common use of these drugs, both over-the-counter and prescription drugs have driven market growth. Funding from...
PR Newswire
30/10/2023

Australian Firefighters Calendar 2024 turns up the heat and promises a year to…

Since its launch in 1993, the calendar has donated over 3.4 million dollars to charities across Australia. The calendar's proud history of supporting animal refuges and Australian Wildlife in the past, will continue into the future. Australia's Rural Firefighters and children suffering from Cancer will also once again benefit from donations. Since its launch in 1993, the calendar has donated over3.4 million dollarsto charities acrossAustralia. The calendar's proud history of supporting...
PR Newswire
30/10/2023

Sobi publishes Q3 2023 report: Strong revenue and solid performance

Outlook 2023 - unchanged Outlook 2023 - unchanged "We are very pleased with Sobi's development during the quarter. Revenues increased for Haematology and Immunology89 per cent of this was driven by our launch medicines, primarily in the US and internationally. This includes a strong contribution from Vonjo, added through our recent acquisition of CTI BioPharma," said Guido Oelkers, President & CEO. Investors, analysts, and media are invited to participate in a conference call...
PR Newswire
30/10/2023

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – October 30, 2023 – 8.00 AM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received transparency notifications as follows: Oxurion received a first transparency notification on October 27, 2023, from Atlas...
Nasdaq GlobeNewswire
30/10/2023

Novartis investigational atrasentan Phase III study demonstrates clinically…

Ad hoc announcement pursuant to Art. 53 LR Phase III ALIGN study met its primary endpoint, demonstrating superiority of atrasentan vs. placebo in proteinuria reduction at 36-week interim analysis 1 ; the safety profile of atrasentan was consistent with previously reported data 1,2-4 IgAN is a progressive kidney disease, affecting mostly young adults, and is a major cause of chronic kidney disease and kidney failure worldwide 5 Novartis plans to review interim results...
Nasdaq GlobeNewswire
30/10/2023

Pfizer Holds MERA Vaccines Summit to Discuss the Impact of Vaccines on…

They also discussed how critical it is for vaccine strategies to be implemented during mass gatherings that are considered high-risk events like the Hajj pilgrim to prevent infectious disease outbreaks. In light of the pandemic, these strategies are especially important to counter the emergence of new disease variants to reduce the burden of disease in those at most risk of hospitalization or poor outcomes. They also discussed how critical it is for vaccine strategies to be implemented during...
PR Newswire
30/10/2023
Altri  Comunicati